Catena Biosciences
YC S21San Francisco, US · Founded 2020 · 7 employees · 7 known investors
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors. The company's technology enables therapeutic structures that deliver dual payloads to cancer targets.
BiotechDeep TechHealthtechMedical DevicesTherapeuticsUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S21)
Catena Biosciences was founded in 2020 by Marco Lobba and Matthew Francis.
ML
Marco LobbainFounderHe holds a Ph.D. from UC Berkeley, where his doctoral research spanned the labs of Matt Francis and Jennifer Doudna.
MF
Matthew FrancisinFounder
Investors · 7
Funding
SEC filings, press & company announcements- Undisclosed amountSeedOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Catena Biosciences do?
- Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors. The company's technology enables therapeutic structures that deliver dual payloads to cancer targets.
- Who founded Catena Biosciences?
- Catena Biosciences was founded by Marco Lobba, Matthew Francis in 2020.
- Who are Catena Biosciences's investors?
- Catena Biosciences's investors include Civilization Ventures Management, Llc, Iaso Ventures, Y Combinator, Axial VC, LongeVC, MBX Capital, Social Impact Capital.
- Where is Catena Biosciences headquartered?
- Catena Biosciences is headquartered in San Francisco, US.